Skip to content
Topics/Toxicology

Digitalis Glycosides

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 3
Medium · 6
Hard · 1

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
27M with Intentional Digoxin Overdose

A 27-year-old man presents after an intentional overdose of 8 mg of digoxin, presenting with nausea, vomiting, and ventricular tachycardia.

hard
~15 min
Pro
35F with Palpitations after Herbal Weight Loss Supplement

A 35-year-old female presents with severe nausea and palpitations after consuming an herbal weight loss product purchased online.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

  • The Pump Failure: Cardiac glycosides (e.g., digoxin) exert their toxicity by binding to and poisoning the cell transmembrane Na⁺-K⁺-ATPase pumps.
  • The Intracellular Shift: This blockade prevents sodium from exiting the cell, leading to a rise in intracellular sodium. This subsequently impairs the Na⁺/Ca²⁺ exchanger, causing a massive intracellular influx of calcium. This calcium surge drives the increased myocardial contractility but dangerously decreases automaticity.
  • The Extracellular Threat: Because the Na⁺-K⁺-ATPase pump is halted, potassium cannot be shifted back into the cells. This results in profound extracellular hyperkalemia, which is the primary driver of lethality in acute toxicity.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Immediate Stabilization: Secure the airway, establish large-bore IV access, and place the patient on continuous cardiac monitoring.
  • The Definitive Antidote: Administer Digoxin Immune Fab (Digibind) immediately for severe toxicity. (Note: The exact weight-based or level-based vial dosing calculation for Digibind is not detailed in the provided sources and must be independently verified via your institution's toxicology protocols).
  • Critical Titrations & Targets:
  • Aggressively monitor serum potassium. Hyperkalemia is the true killer; patients rarely survive when serum potassium levels exceed 5.5 mEq/L.
  • If the patient exhibits hemodynamically significant bradydysrhythmias, administer Atropine; however, be prepared for this to be frequently unsuccessful, necessitating prompt escalation to Digibind.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • The "Can't-Miss" Mimics:
  • Beta-Blocker Toxicity: Also presents with severe bradycardia, hypotension, and cardiotoxicity, but typically causes hypoglycemia rather than profound hyperkalemia. (Note: external sources often cite normal glucose, but they share cardiotoxic shock profiles).
  • Calcium Channel Blocker Toxicity: Mimics the bradycardic shock state but classically presents with hyperglycemia.
  • Cyclic Antidepressant Toxicity: Another severe cardiotoxic ingestion that must be ruled out, especially in polypharmacy overdoses.
  • Prioritized Diagnostic Workup:
  • STAT Serum Potassium: The single most critical laboratory value to dictate immediate antidote administration.
  • 12-Lead ECG: Essential to identify rhythm disturbances (e.g., PVCs, biventricular tachycardia).
  • Digoxin Level: While a quantitative level confirms the exposure, do not delay Digibind administration while awaiting this result if the patient is unstable or hyperkalemic.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • The Toxicity Rhythms: Look immediately for Premature Ventricular Contractions (PVCs), which are the most common ECG finding in digoxin toxicity. In severe toxicity, look for Biventricular Tachycardia, characterized by a beat-to-beat alteration of the frontal QRS axis.
  • The "Digoxin Effect" (Non-Toxic): Do not confuse therapeutic use with toxicity. Digoxin use produces a classic "scooped" ST segment (often called the "Salvador Dali mustache"), PR prolongation, and a shortened QT interval. These findings alone do not indicate toxicity.
  • Physical Exam (Ocular): Assess the patient for specific visual changes, classically reporting yellow halos around lights.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • Absolute Indications for Digoxin Immune Fab (Digibind):
  • Serum potassium level strictly > 5.0 mEq/L.
  • Severe ventricular dysrhythmias.
  • Hemodynamically significant bradydysrhythmias that are unresponsive to atropine.
  • Rapidly progressive rhythm disturbances or a rising potassium level.
  • Co-ingestion of other cardiotoxic drugs (e.g., beta-blockers, CCBs, cyclic antidepressants).
  • Ingestion of a plant known to contain cardiac glycosides accompanied by severe dysrhythmias.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • The ECG Misinterpretation Trap: Pitfall: A trainee sees a "scooped" ST segment and shortened QT interval and prematurely anchors on acute toxicity, initiating unnecessary antidotes. Critical Action: Recognize that the "Salvador Dali mustache" is merely a sign of digitalis use. Base your toxicity diagnosis on PVCs, biventricular tachycardia, hyperkalemia, and clinical instability.
  • The Potassium Blindspot: Pitfall: Waiting for a serum digoxin level to return from the lab before treating a bradycardic patient with a potassium of 6.0 mEq/L. Critical Action: Hyperkalemia > 5.0 mEq/L in the setting of digoxin overdose is an absolute, independent indication to push Digibind. Survival drops precipitously once potassium exceeds 5.5 mEq/L.

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Yellow halos" (visual changes).
  • Botany/Toxin Buzzwords: Ingestions of Foxglove (Digitalis spp.), Common Oleander (Nerium oleander), Lily of the Valley (Convallaria majalis), Yellow Oleander (Thevetia peruviana), or Cane Toad Venom.
  • Pathognomonic Rhythm: "Beat-to-beat alteration of the frontal QRS axis" = Biventricular Tachycardia (severe toxicity).
  • Distractor Options: A question asks for the most common ECG finding in digoxin toxicity, offering "Shortened QT interval with a scooped ST segment." Correction: This is a distractor for therapeutic use. The correct answer is "Premature ventricular contractions (PVCs)".

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • The Initial Resuscitation: "The patient is presenting with pale skin, hypotension, and visual complaints of yellow halos. I am immediately securing the airway, establishing large-bore IV access, and placing them on continuous cardiac monitoring. I will order a STAT 12-lead ECG, focusing on the presence of PVCs or biventricular tachycardia."
  • The Diagnostic Pivot: "Given the suspicion for cardiac glycoside toxicity, whether from pharmaceuticals or a plant ingestion like Foxglove or Oleander, my immediate priority is the patient's serum potassium level, not just the digoxin level."
  • The Definitive Action: "The lab reports a serum potassium of 5.6 mEq/L. Because patients rarely survive a potassium > 5.5 mEq/L in this setting, this is an absolute indication for reversal. I am immediately ordering Digoxin Immune Fab (Digibind) and contacting medical toxicology for continued guidance."